|Bid||0.00 x 900|
|Ask||0.00 x 1100|
|Day's range||44.01 - 45.45|
|52-week range||35.33 - 64.02|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||883.60|
|Earnings date||15 Feb 2023 - 20 Feb 2023|
|Forward dividend & yield||1.80 (3.96%)|
|Ex-dividend date||30 Sept 2022|
|1y target est||53.00|
CHICAGO, November 18, 2022--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") has continued its Environmental, Social and Governance (ESG) leadership, earning its sixth consecutive Nareit Health Care "Leader in the Light" award for superior and longstanding sustainability practices. The Company also earned Bronze in Nareit’s fourth annual Diversity, Equity & Inclusion (DE&I) Recognition Awards. Nareit presented Kelly Meissner, Vice President, Corporate ESG & Sustainability for Ventas, with th
CHICAGO, November 11, 2022--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that management will participate in investor meetings at Nareit’s REITworld 2022 Annual Conference (the "Nareit Conference") on November 15-16, 2022.
Ventas (VTR) reports better-than-anticipated revenues. The SHOP same-store NOI improves on solid demand and pricing power.